Aconitum species are well-known for their contents of C 19 and C 20 diterpenoid alkaloids. Some of these (e.g., aconitine) are highly toxic and some exhibit powerful biological activities, for example antiarrhythmic [1, 2] , analgesic [2] , antiinflammatory [2] , antiepileptic [2] and antiproliferative [3] , making them potential new pharmaceutical entities. Aconitum naviculare (Brühl) Stapf (Ranunculaceae) is a biennial medicinal herb of Alpine grassland (>4000 m a.s.l.) found in the trans-Himalayan region of Nepal, i.e., the Manang, Mustang and Dolpa districts. The aerial parts are used in Nepalese and Tibetan folk medicine against cold, fever and headache, as well as for sedative and analgesic remedies [4, 5] . In the Manang region, the aerial parts are collected during flowering. The local inhabitants usually dry the whole plant and prepare a bitter decoction, which is used for various medicinal purposes. Although Manangis living in and outside Manang commonly use A. naviculare, it has not yet become an item of trade. Due to its supposed high effectiveness in traditional healthcare, A. naviculare may become a potential source of income for mountain people. Little information is available regarding the phytochemical composition of A. naviculare. Gao et al. [4] reported the isolation of a new diterpenoid alkaloid and some atisine-like alkaloids. We recently reported three novel glycosylated flavonoids from this plant [6] . Here we report the isolation and characterization of two new diterpenoid alkaloids, navirine B (1) and navirine C (2), and five known compounds (3-7) from A. naviculare.
The isolated diterpenoid alkaloids 1-3 were also studied for their ability to affect tumor cell proliferation. In particular, antiproliferative activity against ovarian (2008 cells) and colon (LoVo cells) adenocarcinoma was tested. Long-range correlations observed from the aromatic doublet δ H 7.12 (H-3' 5') with the carbon at δ C 33.3 (C-7') and from the methyl group at δ H 2.59 (CH 3 -9') with the carbon at δ C 52.5 (C-8') suggested the presence of one hordenine moiety in the molecule.
NOESY data and comparisons with the spectral data of Gao et al. [4] for navirine evidenced the relative stereochemistry of the molecule, supporting an α orientation for groups at positions 10, 8 and 12. NOESY cross-peaks were also obtained between the exchangeable proton signal at δ 3.48 (OH-5) and H-9 (δ 1.64), which were assigned as β on the basis of previous references [4, 7] , suggesting a β orientation for the hydroxy group. With all this evidence, compound 1 was established as a new alkaloid, called navirine B (5β-hydroxy navirine).
The HRAPITOFMS of compound 2 displayed a protonated molecular ion [M+H] + at m/z 461.3532, corresponding to a molecular formula of C 31 H 45 N 2 O . The 1 H NMR spectrum of compound 2 was quite similar to that of compound 1, but there were some differences. It lacked the signal for the imino proton, and the proton signal of H-20 was shifted downfield to δ 2.53 (δ 3.57 for 1). In addition, a singlet signal integrating for nine protons was observed at δ 2.50, supporting the presence of three nitrogen linked methyl groups. Extensive analyses of COSY, HMQC and HMBC data revealed a similar diterpenoid skeleton, as well as the same hordenine moiety as found in compound 1. In the HMBC spectrum, long-range correlations were observed between the methyl group at δ 1.00 (CH 3 -18) and carbon resonances at δ 34.1 (C-3), 41.7 (C-4), 53.5 (C-5) and 58.0 (C-19), which supported the presence of aminolinked CH 2 at position 19 (δ H 2.30; δ C 58.0), as well as a CH group at position 5 (δH 1.26; δC 53.5). The β configuration for H-5 was established on the basis of the NOESY correlation observed from the methyl group at δ 1.00 and the proton signal at δ 1.26 (H-5). Complete analyses of 1D and 2D NMR data afforded a novel structure, called navirine C. C-15) . The β orientation of the OH group at position 15 was deduced on the basis of NOESY cross-peaks observed between H-15 and H-13 and H-14. The proton and carbon resonances at position 15 were at δ H 3.70 and δ C 74.7 respectively, due to the β-OH group. The H 9 configuration in compound 3 was established by observing the NOESY correlations from the methyl group 18 (δ 1.06) and H-5 (δ 1.38), and from this latter and the H-9 signal (δ 2.19). On the basis of the spectral data, compound 3 was established as chellespontine [8] .
To our knowledge alkaloid 3, flavonol glycosides 4 and 5, and phenylpropanoid glycosides 6 and 7 have been isolated and characterized from A. naviculare for the first time.
Recently some Aconitum alkaloids have been evaluated for their antiproliferative activity against A172 malignant cells [3] . For this reason, we decided to study this activity for the isolated diterpenoid alkaloids 1-3. Compounds 1 and 3 showed a significant antiproliferative activity, whereas compound 2 was inactive. The capacity of the compounds to affect tumor cell growth revealed a dose-dependent effect. In particular, colon cell line LoVo was more sensitive than ovarian cells 2008. In fact, compounds 1 and 3 were able to decrease cell proliferation in LoVo cells, whereas, in 2008 cells, only compound 1 induced a marked inhibition of cell growth, as shown in Table 1 as IC 50 values.
Our study on the phytochemical composition of A. naviculare may be useful in improving scientific knowledge of this Nepalese medicinal plant.
Experimental
Optical rotations were measured on a Jasco P2000 digital polarimeter, IR spectra on a Perkin Elmer 1600 FT-IR spectrometer, and NMR spectra, in CDCl 3 or CD 3 OD, on a Bruker AMX-300 spectrometer, operating at 300. 13 HRMS were obtained on an API-TOF spectrometer (Mariner Biosystems). Samples were diluted in a mixture of H 2 O-AcCN (1:1), with 0.1% formic acid for positive ion mode, and directly injected at a flow rate of 10 µL/min. Sephadex LH 20 and silica gel 60 were used for column chromatography. Silica gel plates were used for preparative and analytical TLC (Merck cat. 5717 and 5715). Compounds on TLC were detected with a UV lamp (254 nm) and by treating plates with Dragendorff's reagent. Semi-preparative HPLC was performed on a Gilson series 305 liquid chromatograph equipped with a LiChrosphere 100 RP-18 column (particle size 10 μm, 250 x 10 mm ID, E. Merck). Fraction EA-II was subjected to silica plate chromatography using chloroform/methanol 4:1 as eluent. Further purification was achieved by semi-preparative HPLC with aqueous 0.1% HCOOH (A) and AcCN (B) as eluents. Gradient elution was used from 90% (A) to 85% (A) in 4 min, and then to 40% (A) in 22 min, yielding compound 3 (5.2 mg).
The AQ fraction was subjected to several semipreparative HPLC steps (Spherisorb C-18, 1 x 300 mm, 10 μm) with aqueous 0.1% HCOOH (A) and methanol (B) as eluents. Gradient elution used for the isolation of compounds 4-7 was as follows: from 90% (A) to 85% (A) in 10 min, and then to 70% (A) in 15 min, yielding compounds 4 (11.0 mg) and 5 (13.0 mg); from 75% (A) to 45 % A in 25 min for the isolation of compounds 6 (8.0 mg) and 7 (6.5 mg). Cell growth was determined by the MTT reduction assay [12] after 72 h of incubation. Briefly, 20 μL of MTT solution (5 mg/mL in PBS) was added to each well and plates were incubated for 4 h at 37°C. DMSO (150 μL) was added to all wells and mixed thoroughly to dissolve the dark blue crystals. Absorbance was measured on a micro-culture plate reader (Titertek Multiscan) at a test wavelength of 570 nm and a reference wavelength of 630 nm. Experiments were performed at least in triplicate, and results were statistically evaluated using Student's t-test [13] . IC 50 95% confidence limits were estimated with the Litchfield and Wilcoxon method.
